EUVIMEDEUVIMED entdecken
Fallbericht

Mixed-Pattern Autoimmune Hemolytic Anemia with Multi-Organ Failure Temporally Associated with Semaglutide Initiation: A Case Report

Samuel R. Briggs, David Rabinovich, Vatche Tchekmedyian

Journal of Maine Medical Center · 18.09.2026 · 8 (2)

DOI: 10.46804/2641-2225.1265 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Maine Medical Center, online erschienen am 18.09.2026. Verfasst von Samuel R. Briggs und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autoimmune hemolytic anemia (AIHA) is a rare but potentially fatal disorder mediated by autoantibodies against red blood cell antigens. Drug-induced immune hemolytic anemia is a recognized, though uncommon, etiology that is historically associated with antimicrobials and chemotherapeutics. Glucagon-like peptide-1 receptor agonists have not previously been implicated in immune hemolysis.Clinical Findings: A 53-year-old woman with obesity presented with syncope, dyspnea, abdominal pain, and jaundice 17 days after initiating semaglutide. Her hematocrit was 11%; hemoglobin, lactate dehydrogenase, bilirubin, and transaminases were unmeasurable due to severe hemolysis. Leukocytosis (39.6 × 109/L), thrombocytopenia (100 × 109/L), acute kidney injury, and shock liver were present. Peripheral smear showed red cell agglutination, spherocytosis, reticulocytosis, and nucleated red blood cells. Direct antiglobulin testing (DAT) was positive for immunoglobulin G and C3d; the eluate was negative on 2 occasions.Clinical Course: Treatment required emergent transfusion, high-dose intravenous methylprednisolone, plasma exchange, intravenous immunoglobulin, rituximab, and eculizumab. Acute kidney injury progressed to anuria that required hemodialysis for 1 month. Infectious, autoimmune, and lymphoproliferative workup was unrevealing. The DAT results normalized within 6 weeks of semaglutide discontinuation. Hemoglobin, renal function, and hepatic enzymes normalized by 4 months. The patient continued to have normal blood counts without any evidence of hemolysis at 1 year.

Conclusions

This case describes life-threatening AIHA with multi-organ failure temporally associated with semaglutide. The negative eluate and rapid DAT result normalization after drug discontinuation are consistent with drug-induced immune hemolytic anemia. Clinicians should consider drug-induced etiologies in new AIHA presentations, particularly with recently initiated agents.

Zitieren

APA

Briggs, S. R., Rabinovich, D., & Tchekmedyian, V. (2026). Mixed-Pattern Autoimmune Hemolytic Anemia with Multi-Organ Failure Temporally Associated with Semaglutide Initiation: A Case Report. Journal of Maine Medical Center, 8(2). https://doi.org/10.46804/2641-2225.1265

Vancouver

Briggs SR, Rabinovich D, Tchekmedyian V. Mixed-Pattern Autoimmune Hemolytic Anemia with Multi-Organ Failure Temporally Associated with Semaglutide Initiation: A Case Report. Journal of Maine Medical Center. 2026;8(2). doi:10.46804/2641-2225.1265

BibTeX
@article{Briggs2026,
  author = {Briggs, Samuel R. and Rabinovich, David and Tchekmedyian, Vatche},
  title = {Mixed-Pattern Autoimmune Hemolytic Anemia with Multi-Organ Failure Temporally Associated with Semaglutide Initiation: A Case Report},
  journal = {Journal of Maine Medical Center},
  year = {2026},
  volume = {8},
  number = {2},
  doi = {10.46804/2641-2225.1265}
}
Kostenlos starten →